How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome?
Skryabin, Valentin Yu, Zastrozhin, Mikhail S., Torrado, Marco V., Grishina, Elena A., Ryzhikova, Kristina A., Shipitsyn, Valery V., Galaktionova, Tatiana E., Sorokin, Alexander S., Bryun, Evgeny A., SJournal:
Drug Metabolism and Personalized Therapy
DOI:
10.1515/dmpt-2019-0026
Date:
March, 2020
File:
PDF, 602 KB
2020